Series B29 October 2024

Semble secures £10m in Series B funding led by Mercia Ventures to expand in the UK and France.

Mercia Ventures led the £10m Series B investment to support international expansion and product automation.

£10.0MSeries B

Share allotment filed at Companies House

Semble provides a connected practice management platform that consolidates clinical records, billing, and scheduling for private healthcare providers.

London-based healthtech company Semble has secured £10m in a Series B funding round led by Mercia Ventures. The raise included participation from Octopus Ventures, Smedvig Ventures and Triple Point.

The capital will be directed towards supporting the platform's ongoing growth, consolidating its market position in the UK, and expanding its presence in France following its recent launch there. Additionally, the funds will be used to drive automation, enhance integration capabilities, and incorporate artificial intelligence features.

Previously known as Heydoc, Semble was founded by Christoph Lippuner and Mikael Landau to address inefficiencies in medical administration. The platform is currently utilised by more than 10,000 healthcare professionals across over 70 specialties.

From the founder

"Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient. With this latest funding, we are looking to bring Semble to professionals across the UK and France, empowering them to spend more time on patient care. We will continue to invest heavily in workflow automation and integrations, positioning Semble at the forefront of AI-driven solutions, and ultimately creating a more connected healthcare ecosystem."

Christoph Lippuner

CEO and Co-founder at Semble

Investor perspective

"The healthcare market is experiencing significant growth, but the industry’s continued reliance on legacy systems poses a real threat to its future. Semble is pioneering an all-in-one clinical system that enables healthcare businesses to automate many aspects of their practice. This investment will help Semble accelerate product development and expand its presence in the UK and France, empowering healthcare organisations to deliver on their digital transformation and transform their patients’ experience. With the founders’ first-hand understanding of the challenges in the healthcare sector and its rapid growth to date, we are in no doubt that Semble is well poised to seize this massive market opportunity."